Dr. Kristina Deligiannidis, MD – Glen Oaks, NY

Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the NIH. Dr. Deligiannidis completed additional NIH research training during medical school and residency. She received an MD from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institute for Medical Research/Zucker School of Medicine at Hofstra/Northwell in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology.

Dr. Deligiannidis is the Director of Women’s Behavioral Health at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle and pregnancy/postpartum periods.

Dr. Deligiannidis conducts grant-funded research in the causes of perinatal depression and in novel therapeutics. Her research interests include psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in postpartum depression. Dr. Deligiannidis's research efforts have been nationally recognized. She is the recipient of federal, foundation and industry research funding including prestigious K23 and R01 grants from the NIMH and numerous awards for research and teaching of medical students and residents. Dr. Deligiannidis’s research has been covered by major media outlets including the Boston Globe, Boston WCVB ABC News, Boston WBZ CBS News, CBS-2-NY, ABC-7 NY, National Public Radio and Newsday, among others.

Dr. Deligiannidis actively participates in and holds leadership positions in national scientific committees, gives presentations nationally and serves as grant reviewer for the NIH.